格隆汇3月7日丨Cara Therapeutics(CARA.US)盘前跌31.14%,报6.9美元。公司2022年Q4财报实现营收326.1万美元,预期值为1625万美元,比市场预期低79.93%;每股收益为-0.56美元,预期值为-0.32美元,... 网页链接
$Cara Therapeutics(CARA)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001558370-24-007964 Act: 34 Size: 8 MB 网页链接
$Cara Therapeutics(CARA)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001104659-24-060529 Act: 34 Size: 285 KB 网页链接
$Cara Therapeutics(CARA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-012322 Size: 5 KB 网页链接
$Cara Therapeutics(CARA)$ DEF 14A Other definitive proxy statements Accession Number: 0001104659-24-049971 Act: 34 Size: 1 MB 网页链接
$Cara Therapeutics(CARA)$ ARS Annual Report to Security Holders Accession Number: 0001104659-24-049982 Act: 34 Size: 1 MB 网页链接
$Cara Therapeutics(CARA)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001104659-24-049984 Act: 34 Size: 892 KB 网页链接
$Cara Therapeutics(CARA)$ PRE 14A Other preliminary proxy statements Accession Number: 0001104659-24-046771 Act: 34 Size: 1 MB 网页链接
$Cara Therapeutics(CARA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-010569 Size: 5 KB 网页链接
$Cara Therapeutics(CARA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-010570 Size: 5 KB 网页链接
$Cara Therapeutics(CARA)$ 8-K Current report, item 5.02 Accession Number: 0001104659-24-037855 Act: 34 Size: 195 KB 网页链接